Mr Wissam Abou Chedid : Urology

Fee assured
Verified account
Open Referral network

Overview

Specialises in

Benign Prostate disorders

Urological oncology

Offers

Face-to-face consultations
Video and telephone consultations

About me

Mr Wissam Abou-Chedid is a Consultant Urological and Robotic Surgeon at the Royal Surrey NHS Foundation Trust, internationally recognised for his expertise in robotic-assisted prostate cancer surgery and minimally invasive treatments for benign prostate disease.

He completed his medical degree at the University of Saint Joseph, Beirut, before completing his specialist urology training at Henry Mondor University Hospital, Paris. He further refined his expertise through advanced fellowships in minimally invasive and robotic surgery at Clinique Saint Augustin, Bordeaux, and at the Royal Surrey NHS Foundation Trust in Guildford.

Mr Abou-Chedid is among the highest-volume robotic prostate surgeons in the UK, having performed over 750 robotic procedures in the past four years. He is particularly known for his expertise in Retzius-sparing nerve-sparing robotic prostatectomy, a highly specialised technique designed to optimise continence and erectile function, and he is one of the highest-volume surgeons in Europe performing this procedure.

He is widely recognised for driving innovation in prostate cancer care, including pioneering day-case robotic prostatectomy and implementing patient-directed catheter removal protocols, both aimed at enhancing recovery and improving patient experience. He also championed the acquisition and implementation of the Histolog device, a breakthrough technology enabling real-time intraoperative margin assessment, helping to improve oncological precision during prostate cancer surgery.

In addition to prostate cancer surgery, Mr Abou-Chedid offers a comprehensive range of state-of-the-art treatments for benign prostatic enlargement (BPH), including Aquablation, Echolaser, and Rezum, ensuring patients have access to the most advanced and least invasive treatment options available.

Mr Abou-Chedid is also a dedicated educator and surgical trainer. He is a Robotic and Minimally Invasive Urological Surgery Trainer at IRCAD, and regularly hosts international workshops and masterclasses where urologists visit to observe and learn advanced robotic prostatectomy techniques.

He is committed to improving prostate health outcomes at a national level and serves as a Prostate Cancer UK National Clinical Champion, while actively supporting The Prostate Project charity, promoting awareness, early detection, and patient-centred innovation in prostate cancer care.

Areas of interest

Prostate cancer diagnostics and treatment

Benign enlargement of prostate treatments (Aquablation / Echolaser / Rezum / TURP)

Robotic and minimally invasive surgery

Retzius-sparing nerve preserving prostatectomy

Raised PSA test

Bothersome urinary symptoms

Blood in the urine or semen

Medical secretaries

Anaesthetists worked with

Dr Girish Dhond Not Fee Assured
Dr Leigh Kelliher Fee Assured
Dr Priya Suaris Not Fee Assured

Dr Kayur Patel Fee Assured
Dr Piers M Johnston Fee Assured

About me

External resources

Mr. Abou Chedid Website

Current NHS consultant posts held

Consultant Urological and Robotic Surgeon at the Royal Surrey NHS Foundation Trust

Research interests

My research focuses on advancing prostate cancer treatment, particularly through Retzius-sparing prostatectomy and day-case prostatectomy techniques.
These methods aim to improve patient outcomes by minimizing recovery time and enhancing the precision of surgery.

Additionally, I am committed to pioneering minimally invasive treatments for benign prostatic enlargement, such as Aquablation (Aquabeam), Rezum, and Echolaser, which offer effective, less invasive options for patients suffering from prostate conditions. Through my work, I seek to improve both cancer and benign prostate care, contributing to cutting-edge solutions in urology.

Awards received

As a Prostate Cancer UK Clinical Champion, I have spearheaded innovative initiatives such as day-case robotic prostatectomy and empowering patients to self-remove catheters post-surgery. These advancements have significantly enhanced the quality of care, improving patient autonomy and recovery experiences, and have since been adopted across the UK.

(Additional) Languages spoken

Publications

- Factors associated with pathological up-staging in MRI cT3a prostate cancer � a retrospective study from a high-volume centre.

- Outcomes of robot-assisted radical prostatectomy in men after trans-urethral resection of the prostate: a matched-pair analysis.

- Predictors of biochemical recurrence after robot-assisted radical prosta-tectomy: single-centre analysis.

- Robotic excision of a giant seminal vesicle cyst.

- Gynaecological organ involvement in females undergoing radical cystectomy: a multicentre study.

- Newer therapies and surgical management of ketamine-induced uropathy: A review.

- Assessment of routine same-day discharge surgery for robot assisted radical prostatectomy.

- Self-removal of catheter after robot-assisted radical prostatectomy: a feasibility study.

- Nutritional Management of the Urological Surgical Patient.

- Short-term continence outcomes in men over 75 undergoing robotic-assisted radical prostatectomy.

- Functional and oncological outcomes of robot-assisted radical prostatectomy in obese men: a matched-pair analysis.

- Simultaneous excision of pelvic lipoma and robot-assisted radical prostatectomy.

- The Impact of socio-economic deprivation on recovery following robotic assisted radical cystectomy.

- A pilot study to investigate the effect of topical microporous polysaccharide haemospheres on outcomes following robot-assisted radical prostatectomy.

- The impact of COVID-19 on surgical volume and surgical training at a high-volume pelvic oncology centre.

- Delivering safe and timely cancer care during COVID 19. Lessons and successes from the transition period.

- Patients experience and preference regarding subcutaneous venous thromboembolic prophylaxis following robotic assisted radical cystectomy.

- Are Telephone Consultations the Future of urology in the NHS?

- Spontaneous rupture of ileal neobladder 8 years after surgery: A case report.

- The chemokine CCL20 induces proinflammatory and matrix degradative responses in cartilage.

Courses offered to GPs

1. Elevated PSA and prostate cancer.

2. Minimally invasive treatments for benign enlargement of the prostate such as Aquabeam, Rezum and echolaser.

3. Long term Catheters, is there a better way?

4. Recurrent urinary tract infections.

5. Erectile dysfunction treatment options.

6. Different types of incontinence and how to treat them.

7. how to reduce the risk of kidney stone recurrence?

About my work

View photos of my work

Click an image to enlarge and read a description

View photos of my team

Click an image to enlarge and read a description

My qualifications & training

Qualifications

Fellowship of the Royal College of Surgeons (FRCS) Royal College of Surgeons of Edinburgh 2021
Member of the International Postgraduate Deanery of the Royal College of Surgeons (MIPD) Royal College of Surgeons of Edinburgh 2021
Specialised Medical Training Diploma in Urology University of Paris 2019
Doctor of Medicine Diploma (MD) University of Saint Joseph 2013
Postgraduate Diploma of Andrology University of Paris 2020
Postgraduate Diploma in Laparoscopic Surgery University of Strasbourg 2017
Master’s degree in Biomedical Sciences (MSc) University of Saint Joseph 2013
Postgraduate Diploma in Urodynamics and Pelviperineology University of Paris 2018

GMC registration

Reference number 7771840

Affiliations / memberships

- The Royal College of Surgeons of Edinburgh.

- British Association of Urological Surgeons.

- European Association of Urology.

- American Association of Urology.

My private practice

Finder

Note: